Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PL37 add-on study in diabetic peripheral neuropathic pain
2013-004876-37Phase 2Terminated
- Sponsor
- Pharmaleads
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diabetic polyneuropathy (DPN) comparing PL37 add-on with Placebo add-on (2 arms). Primary endpoint: Change in weekly mean 24-hour average pain intensity. Started Mar 2014; status: terminated.
02
Drugs
PL37
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on 2013-004876-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004876-37.